Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results
Initiated the Phase 1b/2a PACIFIC Study, evaluating LP352 in [...]
Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors
Nov 17, 2021 Download PDF Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), [...]